CLRB

Conviction 13HealthcareScan · Mon, Aug 10, 2026

Three white soldiers

CLRB$2.60+1.17%

ResistanceSupportVol 14Insider buy

Vol MA14 41.33K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Cellectar Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.cellectar.com ↗

Price2.60

Change+1.17%

Gap+0.00%

Rel volume0.02×

Avg volume76.97K

Avg $ vol198K

SMA 202.54

SMA 502.58

SMA 2003.02

Price vs 50+0.68%

Price vs 200-13.89%

MA stackmixed

50/200 cross—

Supertrenddown · 2.92

RSI (14)52

MACD hist0.01

MACD crossbull · 6d

Stoch %K / %D73 / 63

ADX (14)16

+DI / −DI16 / 12

RSI divergence—

MACD divergence—

ATR %+6.00%

ADR %5.77%

52w high6.17

52w low2.23

From 52w high-57.86%

Above 52w low+16.59%

New 52w highNo

SqueezeOn · 7d

Bollinger width10.25%

%B0.75

Donchian pos55.67%

Donchian high2.82

Donchian low2.33

AVWAP (52w high)3.55

vs AVWAP high-26.76%

AVWAP (52w low)2.61

vs AVWAP low-0.35%

OBV trendDown

Chaikin MF (20)-0.29

Today vs 20d0.02×

Avg vol (14d)41.33K

Avg vol (20d)76.97K

Avg $ vol (20d)198K

Market cap20.78M

RS 3m (vs SPY)-27.82%

RS 6m (vs SPY)-22.98%

RS line new highNo

Trend template1/8

Technical rank27.6

1 week-2.26%

1 month-7.80%

3 months-16.13%

6 months-14.47%

1 year-44.80%

YTD-25.07%

P/E-0.95

P/B6.23

P/S—

P/FCF-0.90

EPS-8.35

Div yield—

ROE-653.39%

ROA-195.97%

Debt/Eq0.10

Current1.90

EV/EBITDA-0.56

Gross margin—

Net margin—

Rev growth—

EPS growth51.12%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value12.76M

Revenue—

Net income-5.65M

Gross profit—

Free cash flow-23.12M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out7.99M

Employees11

ListedTue, Apr 19, 2005

Free float7.61M

Float %95.2%

Short interest199.44K

Days to cover1.7d

Short volume68.3%

Squeeze score32 / 100

Next earningsThu, Aug 13, 2026 · pre-mkt (3d)

EPS forecast−$0.55 · 2 est

Last EPS vs est−$1.33 vs −$1.35

Last surprise+1.5% beat

Setup gradeD

Conviction13 / 100

Pattern quality—

Tech rank27.6 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree white soldiers

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CLRB

All disclosures →

No recent disclosed trades by Congress in CLRB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CLRB · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Loren Stefan Insider · Stock option (right to buy) · 2026-07-08	Grant	15K	—	2026-07-08	2026-07-10
Loren Stefan Insider · Stock option (right to buy) · 2026-07-08	Grant	15K	—	2026-07-08	2026-07-08
NEIS JOHN Director · Stock option (right to buy) · 2026-07-07	Grant	25K	—	2026-07-07	2026-07-08
Swirsky Douglas J Director · Stock option (right to buy) · 2026-07-07	Grant	37.5K	—	2026-07-07	2026-07-08
Longcor Jarrod Chief Operating Officer · Stock option (right to buy) · 2026-07-07	Grant	118K	—	2026-07-07	2026-07-08
Gu Andrew Director · Stock option (right to buy) · 2026-07-07	Grant	25K	—	2026-07-07	2026-07-08
DRISCOLL FREDERICK W Director · Stock option (right to buy) · 2026-07-07	Grant	25K	—	2026-07-07	2026-07-08
Kolean Chad J CFO · Stock option (right to buy) · 2026-07-07	Grant	92K	—	2026-07-07	2026-07-08
Chanan-Khan Asher Director · Stock option (right to buy) · 2026-07-07	Grant	25K	—	2026-07-07	2026-07-08
CARUSO JAMES V President & CEO · Stock option (right to buy) · 2026-07-07	Grant	250K	—	2026-07-07	2026-07-08

SEC filings

EDGAR filings in CLRB · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.